Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses mucocutaneous manifestations associated with Covid-19, classifies the lesions, and describes their characteristics and treatments but reports no new clinical findings.

This study discusses experiences with managing postoperative complications after bariatric surgery, such as psychological disorders, hair loss, nutritional deficiencies, and other issues, highlighting the need for effective interventions to prevent comorbidities while acknowledging the procedure's generally low complication rates.

This study, using interviews with educators from public and private schools in Cabanatuan City, found that resilience through faith and positivity helped them survive the challenges of Covid-19, highlighting the need for institutional support during health crises.

This article provides tables summarizing various medical conditions and symptoms related to COVID-19, sepsis, and cardiovascular issues, but it does not report new research findings.

This review discusses the antiviral potential of cepharanthine against SARS-CoV-2, noting its effectiveness in preclinical models but presenting no new clinical results.

This case study potentially links the use of anabolic steroids to increased severity of COVID-19 in a healthy 28-year-old man, with marked symptom improvement following treatment with proxalutamide.

This study found that a 14-day treatment with proxalutamide significantly reduced the 28-day mortality rate in hospitalized COVID-19 patients compared to placebo, with greater benefits observed among those who adhered to the treatment.

This study found that treating asymptomatic or mild COVID-19 with cepharanthine did not significantly reduce the time to a negative test result, though 60 mg/day showed a non-significant trend needing further validation.

This review covers the potential of repurposing existing drugs for treating COVID-19 and updates on virus- and host-targeting drug candidates, reporting no new experimental results.

This review found that while many medicinal plants show potential antiviral and other therapeutic effects against COVID-19 based on prior studies, more rigorous clinical trials are needed to confirm their efficacy and safety.

This narrative review discusses the challenges and special care needs of laryngectomy patients with tracheoesophageal bypass during the COVID-19 pandemic and reports no new clinical results.

In this study, D-dimer and procalcitonin elevation were identified as potential indicators for intensive care needs in COVID-19 pneumonia patients, highlighting differences in nursing care requirements compared to non-COVID-19 pneumonia patients.

This report details the first two cancer patients with COVID-19 and co-infection cases at the Instituto Nacional de Cancerología, ESE, and presents their clinical symptoms and complications.

This study suggests that sex hormone does not significantly impact the prevalence or clinical outcomes of COVID-19 in South Korean patients.

This study found low- to very low-quality evidence suggesting that several pharmacological treatments, including alpha blockers and antibiotics, may reduce prostatitis symptoms without significantly increasing adverse events in the short term, although more rigorous trials are needed.

This study found that women, younger individuals, and those with a low body mass index were more likely to develop long COVID symptoms, and even mild COVID-19 cases often experienced long-term residual symptoms.

More research is needed to understand sex and racial differences in long COVID.

This study found that most women who recovered from COVID-19 in one Brazilian neighborhood experienced lingering symptoms like fatigue and headache, with few undergoing rehabilitation.

This review describes the signs, symptoms, and complications of COVID-19, noting that symptoms often overlap with common and non-specific features, especially in older adults and in different stages of illness.

This study found that stress and its related symptoms were highly prevalent among university students in Egypt during the third wave of the COVID-19 pandemic, with most reporting negative coping strategies.

In this study, researchers found an increase in daily physical activity during the COVID-19 pandemic among students, with a notable rise in leisure walking and transportation, but also increased weekday sedentary behavior in men.

This study demonstrated that a computational screening process can identify existing drugs and natural compounds with potential anti-COVID-19 activity, highlighting some candidates for further experimental validation.

In this study, researchers observed that individuals with alopecia areata exhibited significant changes in scalp microbiota diversity and composition, which were linked to disease severity and inflammation markers, though it remains unclear if these microbial shifts are a cause or a result of hair loss.

This letter to the editor discusses a potential link between new onset alopecia areata and SARS-CoV-2 infection, but reports no new clinical results.

This study observed that telogen effluvium, or acute hair loss, often occurs 1 to 3 months after SARS-CoV-2 infection, earlier than classic telogen effluvium.

This review suggests that understanding the biological and molecular reasons for more severe COVID-19 in men, particularly those at risk for prostate cancer, could improve management of these patients, but reports no new results.

This review discusses the role of ADAM 17 in gynecological disorders, particularly PCOS, and suggests its potential for therapeutic intervention, but reports no new clinical results.

This consensus highlights that addressing nutritional and endocrine deficiencies through lifestyle modifications, nutritional support, and medical interventions is crucial for managing hair loss associated with endocrine and gynecological disorders, emphasizing the need for a multidisciplinary approach involving dermatologists, nutritionists, endocrinologists, and gynecologists.

This review discusses targeting host cell proteases as a novel approach to inhibit SARS-CoV-2 infection, highlighting transcriptional modulation and enzymatic inhibition as promising therapeutic strategies, but it reports no new clinical findings.

This article reviews global insights on how COVID-19 has transformed the practice of dermatology, but it reports no new clinical results.